1,023 Views | 600 Downloads
Address correspondence to: Jens Titze, Division of Clinical Pharmacology, Vanderbilt University Medical Center, 2213 Garland Avenue, P435F MRBIV, Nashville, Tennessee 37232, USA. Phone: 615.343.1401; E-mail: jens.m.titze@vanderbilt.edu.
See publication for full list of author contributions.
We thank N. Mizushima (University of Tokyo) for providing GFP-LC3#53 mice.
We are grateful to the excellent technical assistance of Yan Zhao (Vanderbilt University Medical Center, Nashville, TN, USA), Jenny Hähnel, and Ulrike Goller (University Clinic Erlangen, Erlangen, Germany).
The authors have declared that no conflict of interest exists.
This work was supported by grants from the NIH (RO1 HL118579-01, to JT; R01-DK41707 and R01-DK89828, to JS; and U24 DK059637, to DHW); the American Heart Association (AHA) (14SFRN20770008); the German Federal Ministry for Economics and Technology/DLR Forschung unter Weltraumbedingungen (50WB1624, to JT); the Deutsche Forschungsgemeinschaft (DFG) (SFB 643 B16, to JT and JJ; DA 1835/1-1, to SD); the TOYOBO Biotechnology Foundation (to KK); and the Interdisciplinary Center for Clinical Research Erlangen (to JT).
© 2017, American Society for Clinical Investigation